# FDA Inspection 1009946 - UCLA Health, UCLA Blood & Platelet Center - April 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/ucla-health-ucla-blood-platelet-center/2d50d9b9-5f20-46bd-9015-8d72e0c23665
Source feed: FDA_Inspections

> FDA Inspection 1009946 for UCLA Health, UCLA Blood & Platelet Center on April 26, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009946
- Company Name: UCLA Health, UCLA Blood & Platelet Center
- Inspection Date: 2017-04-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1314324 - 2026-04-15](https://www.keypedia.com/records/fda_inspections/ucla-health-ucla-blood-platelet-center/8187f4ed-3fd8-4167-a737-3309e9dcd471)
- [FDA Inspection 1162394 - 2022-02-10](https://www.keypedia.com/records/fda_inspections/ucla-health-ucla-blood-platelet-center/78a1e3cf-23dc-461b-ac72-7352c157f19c)
- [FDA Inspection 1162394 - 2022-02-10](https://www.keypedia.com/records/fda_inspections/ucla-health-ucla-blood-platelet-center/4d11d52f-8f9c-4885-988f-3a5198d44c16)
- [FDA Inspection 1097758 - 2019-06-18](https://www.keypedia.com/records/fda_inspections/ucla-health-ucla-blood-platelet-center/be51b00b-61ad-499c-8f2d-102ea2fa4bd2)
- [FDA Inspection 1091822 - 2019-05-29](https://www.keypedia.com/records/fda_inspections/ucla-health-ucla-blood-platelet-center/bf992942-dde8-4e93-a519-301c2ba22a0f)

Company: https://www.keypedia.com/companies/ucla-health-ucla-blood-platelet-center/5c722f17-faf1-4898-909d-af0a6bf0bf96

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d